Hexamethylmelamine, adriamycin, and cyclophosphamide (HAC) versus cis-dichlorodiamineplatinum, adriamycin, and cyclophosphamide (PAC) in advanced ovarian cancer: a randomized clinical trial.

Source:http://linkedlifedata.com/resource/pubmed/id/3922639

Download in:

View as

General Info

PMID
3922639